LEK Opens New Production Line

21 May 1995

Slovenian pharmaceutical company LEK has opened a new unit to produce tablets. The plant was opened in Ljubljana by the Slovene Prime Minister, Janez Drnovsek, who described LEK as one of the most successful Slovene companies.

LEK managing director Metod Dragonja said the investment - one of the largest in Slovenia in the past two years - is worth about 40.6 million Swiss francs ($36 million). The new unit will employ 80 people and produce 2 billion tablets a year. LEK's production rose by 25.4% in 1994, and exports reached $165 million.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight